A phase III, randomized, open-label study to assess the...

A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses

Jiri Beran, Ibrahim A. Abdel-Messih, Jolana Raupachova, Lenka Hobzova, Elena Fragapane
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Year:
2010
Language:
english
Pages:
12
DOI:
10.1016/s0149-2918(11)00024-5
File:
PDF, 137 KB
english, 2010
Conversion to is in progress
Conversion to is failed